Literature DB >> 21442767

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

Dietmar Schmidt1, Christine Bergeron, Karin J Denton, Ruediger Ridder.   

Abstract

BACKGROUND: The objective of this study was to analyze the diagnostic performance of a newly established immunocytochemical dual-stain protocol, which simultaneously detects p16(INK4a) and Ki-67 expression in cervical cytology samples, for identifying high-grade cervical intraepithelial neoplasia (CIN2+) in women with Papanicolaou (Pap) cytology results categorized as atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL).
METHODS: Residual liquid-based cytology material from 776 retrospectively collected ASCUS/LSIL cases that were available from a recent study evaluating p16 cytology and HPV testing were subjected to p16/Ki-67 dual staining. The presence of 1 or more double-immunoreactive cell(s) was regarded as a positive test outcome, irrespective of morphology. Test results were correlated to histology follow-up.
RESULTS: Sensitivity of p16/Ki-67 dual-stain cytology for biopsy-confirmed CIN2+ was 92.2% (ASCUS) and 94.2% (LSIL), while specificity rates were 80.6% (ASCUS) and 68.0% (LSIL), respectively. Similar sensitivity/specificity profiles were found for both age groups of women aged <30 years versus women aged ≥30 years. Dual-stain cytology showed comparable sensitivity, but significantly higher specificity, when compared with human papillomavirus (HPV) testing.
CONCLUSIONS: The results of this study show that p16/Ki-67 dual-stain cytology provided a high sensitivity for the detection of underlying CIN2+ in women with ASCUS or LSIL Pap cytology results, comparable to the rates previously reported for HPV testing and p16 single-stain cytology. However, the specificity of this morphology-independent interpretation of p16/Ki-67 dual-stain cytology testing was further improved compared with the earlier p16 single-stain cytology approach, which required morphology interpretation, and it is significantly higher when compared with HPV testing.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442767     DOI: 10.1002/cncy.20140

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  46 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  Relevance of HPV Screening for Triaging Equivocal Cytology Findings in the Pap II-p, Pap III and Pap IIID Groups - Results of Two Long-Term Studies.

Authors:  A Luyten; K U Petry
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

Review 3.  [Indications for p16/Ki-67 in cervical cytology].

Authors:  P Ziemke; H Griesser
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

4.  [The new S3 guideline "Prevention of cervical carcinoma" : What is important for pathology?]

Authors:  D Schmidt
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

Review 5.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

6.  On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

Authors:  Makoto Takeuchi; Kazunori Nagasaka; Mina Yoshida; Yoshiko Kawata; Yuko Miyagawa; Saori Tago; Haruko Hiraike; Osamu Wada-Hiraike; Katsutoshi Oda; Yutaka Osuga; Tomoyuki Fujii; Takuya Ayabe; Soo Hyeon Kim; Teruo Fujii
Journal:  Biomicrofluidics       Date:  2019-07-30       Impact factor: 2.800

7.  Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women.

Authors:  Carolina Areán-Cuns; Maria Mercado-Gutiérrez; Irene Paniello-Alastruey; Fermín Mallor-Giménez; Alicia Córdoba-Iturriagagoitia; Maria Lozano-Escario; Mercedes Santamaria-Martínez
Journal:  Virchows Arch       Date:  2018-08-09       Impact factor: 4.064

Review 8.  [Modern biomarkers for precancerous lesions of the uterine cervix : Histological-cytological correlation and use].

Authors:  D Schmidt
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

Review 9.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

10.  Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.

Authors:  Takuma Fujii; Miyuki Saito; Toshihiko Hasegawa; Takashi Iwata; Hiroyuki Kuramoto; Kaneyuki Kubushiro; Mineo Ohmura; Kazunori Ochiai; Hiroharu Arai; Masaru Sakamoto; Teiichi Motoyama; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2014-04-18       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.